Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1969 1
1970 1
1972 3
1975 2
1976 1
1977 2
1979 6
1980 5
1981 5
1982 3
1983 7
1984 6
1985 5
1986 5
1987 11
1988 12
1989 8
1990 12
1991 8
1992 4
1993 4
1994 10
1995 8
1996 5
1997 5
1998 5
1999 6
2000 4
2001 1
2002 2
2003 3
2004 7
2005 7
2006 3
2007 1
2008 3
2009 1
2010 3
2011 4
2012 2
2013 4
2014 2
2015 7
2016 6
2017 4
2018 5
2019 6
2020 8
2021 4
2022 6
2023 5
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J, Archuleta S, Roberts MA, Cass A, Paterson DL, Foo H, Paul M, Guy SD, Tramontana AR, Walls GB, McBride S, Bak N, Ghosh N, Rogers BA, Ralph AP, Davies J, Ferguson PE, Dotel R, McKew GL, Gray TJ, Holmes NE, Smith S, Warner MS, Kalimuddin S, Young BE, Runnegar N, Andresen DN, Anagnostou NA, Johnson SA, Chatfield MD, Cheng AC, Fowler VG Jr, Howden BP, Meagher N, Price DJ, van Hal SJ, O'Sullivan MVN, Davis JS; Australasian Society for Infectious Diseases Clinical Research Network. Tong SYC, et al. JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103. JAMA. 2020. PMID: 32044943 Free PMC article. Clinical Trial.
Charting the global footprint of borderline oxacillin-resistant Staphylococcus aureus (BORSA): the first systematic review and meta-analysis.
Engku Abd Rahman ENS, Irekeola AA, Yamin D, Elmi AH, Chan YY. Engku Abd Rahman ENS, et al. PeerJ. 2024 Dec 16;12:e18604. doi: 10.7717/peerj.18604. eCollection 2024. PeerJ. 2024. PMID: 39703916 Free PMC article.
Borderline oxacillin-resistant Staphylococcus aureus (BORSA) has been a persistent yet under-researched concern in the realm of antibiotic resistance, characterized by unique resistance mechanisms and potential for severe infections. ...
Borderline oxacillin-resistant Staphylococcus aureus (BORSA) has been a persistent yet under-researched concern in the realm of antib …
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
Grillo S, Pujol M, Miró JM, López-Contreras J, Euba G, Gasch O, Boix-Palop L, Garcia-País MJ, Pérez-Rodríguez MT, Gomez-Zorrilla S, Oriol I, López-Cortés LE, Pedro-Botet ML, San-Juan R, Aguado JM, Gioia F, Iftimie S, Morata L, Jover-Sáenz A, García-Pardo G, Loeches B, Izquierdo-Cárdenas Á, Goikoetxea AJ, Gomila-Grange A, Dietl B, Berbel D, Videla S, Hereu P, Padullés A, Pallarès N, Tebé C, Cuervo G, Carratalà J; SAFO study group. Grillo S, et al. Nat Med. 2023 Oct;29(10):2518-2525. doi: 10.1038/s41591-023-02569-0. Epub 2023 Oct 2. Nat Med. 2023. PMID: 37783969 Free PMC article. Clinical Trial.
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Prosty C, Noutsios D, Lee TC, Daneman N, Davis JS, Jager NGL, Ghanem-Zoubi N, Goodman AL, Kaasch AJ, Kouijzer I, McMullan BJ, McDonald EG, Tong SYC, Ong SWX; Staphylococcus aureus Network Adaptive Platform MSSA/PSSA domain specific working group. Prosty C, et al. Clin Microbiol Infect. 2025 Aug;31(8):1272-1282. doi: 10.1016/j.cmi.2025.04.045. Epub 2025 May 9. Clin Microbiol Infect. 2025. PMID: 40349971 Free article.
A total of 30 observational studies at moderate or high risk of bias were included, which comprised 3869 patients who received cefazolin and 11 644 patients who received antistaphylococcal penicillins (flucloxacillin = 6721, unspecified = 2440, nafcillin = 1305, cloxacillin = 125 …
A total of 30 observational studies at moderate or high risk of bias were included, which comprised 3869 patients who received cefazolin and …
Prulifloxacin.
Keam SJ, Perry CM. Keam SJ, et al. Drugs. 2004;64(19):2221-34; discussion 2235-6. doi: 10.2165/00003495-200464190-00005. Drugs. 2004. PMID: 15456336 Clinical Trial.
Gram-positive organisms, including meticillin- or oxacillin-susceptible Staphylococcus aureus, Enterococcus spp. and Italian community isolates of Streptococcus pneumoniae are susceptible to ulifloxacin. ...
Gram-positive organisms, including meticillin- or oxacillin-susceptible Staphylococcus aureus, Enterococcus spp. and Italian communit …
Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections.
Van der Auwera P, Meunier-Carpentier F, Klastersky J. Van der Auwera P, et al. Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S515-22. doi: 10.1093/clinids/5.supplement_3.s515. Rev Infect Dis. 1983. PMID: 6356280 Clinical Trial.
In a prospective, randomized study of staphylococcal infections, 27 patients received oxacillin plus rifampin and 29 received oxacillin alone. Vancomycin was substituted for oxacillin when the pathogen was demonstrated to be resistant to oxacillin in v …
In a prospective, randomized study of staphylococcal infections, 27 patients received oxacillin plus rifampin and 29 received oxac …
Prophylactic oxacillin in dog bite wounds.
Elenbaas RM, McNabney WK, Robinson WA. Elenbaas RM, et al. Ann Emerg Med. 1982 May;11(5):248-51. doi: 10.1016/s0196-0644(82)80093-0. Ann Emerg Med. 1982. PMID: 7073046 Clinical Trial.
Patients were randomly assigned to receive oxacillin 500 mg QID x 5 days or identically appearing placebo. Home wound care was standardized an patients were observed at least every 2 days. ...Two infections of the hand occurred in patients receiving oxacillin; no in …
Patients were randomly assigned to receive oxacillin 500 mg QID x 5 days or identically appearing placebo. Home wound care was standa …
Evaluation of prophylactic oxacillin in cat bite wounds.
Elenbaas RM, McNabney WK, Robinson WA. Elenbaas RM, et al. Ann Emerg Med. 1984 Mar;13(3):155-7. doi: 10.1016/s0196-0644(84)80604-6. Ann Emerg Med. 1984. PMID: 6696302 Clinical Trial.
Four of six patients receiving placebo, but none of the five receiving oxacillin, developed a wound infection (P = .045). Material obtained from three of these four patients yielded Pasteurella multocida as the responsible organism. Prophylactic oxacillin was thus a …
Four of six patients receiving placebo, but none of the five receiving oxacillin, developed a wound infection (P = .045). Material ob …
Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial.
Burdet C, Saïdani N, Dupieux C, Lemaignen A, Canouï E, Surgers L, Vareil MO, Lefort A, Lepeule R, Peiffer-Smadja N, Charmillon A, Le Moing V, Boutoille D, Tolsma V, Abgrall S, Wolff M, Tattevin P, Esposito-Farèse M, Vandenesch F, Duval X, Tubiana S, Lescure FX; CloCeBa Study Group. Burdet C, et al. Lancet. 2025 Nov 15;406(10517):2349-2359. doi: 10.1016/S0140-6736(25)01624-1. Epub 2025 Oct 17. Lancet. 2025. PMID: 41115439 Free article. Clinical Trial.
Perioperative systemic antibiotics for prophylaxis of infections in breast surgery: sulbactam/ampicillin versus mezlocillin/oxacillin.
Engel K, Wildfeuer A. Engel K, et al. Suppl Int J Gynecol Obstet. 1989;2:29-34. doi: 10.1016/0020-7292(89)90089-1. Suppl Int J Gynecol Obstet. 1989. PMID: 2679681 Clinical Trial.
In a prospective, randomized, open trial, efficacy of one dose of sulbactam/ampicillin (1 g:2 g) was compared to three doses of mezlocillin/oxacillin (2 g:1 g), starting with induction of anesthesia in 80 breast surgery patients with an increased risk of postoperative infe …
In a prospective, randomized, open trial, efficacy of one dose of sulbactam/ampicillin (1 g:2 g) was compared to three doses of mezlocillin/ …
248 results